Skip to content

Alleviating drymouth by mask-wearing for head and neck cancer patients on chemoradiotherapy

Alleviating drymouth by mask-wearing for head and neck cancer patients on chemoradiotherapy - Alleviating drymouth by mask-wearing for head and neck cancer patients on chemoradiotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020041
Enrollment
30
Registered
2015-12-11
Start date
2015-12-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

Group A:wet mask wearing for 9weeks Group B:paper mask wearing for 9weeks

Sponsors

East 13th Floor,Osaka University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The patints on chemotherapy,Cisplatin 20mg/m and Docetaxel10mg/m2,once a week, 6 cycles with the radiotherapy 66Gy or 70Gy 2.PS 0~1 3.able to communication 4.able to wear mask

Exclusion criteria

Exclusion criteria: 1.Patints of the dry mouth or Sjogren's syndrome 2.Patints of respiratory disturbance 3.Patints allergic to mask

Design outcomes

Primary

MeasureTime frame
Evaluation by measured moisture/ oral mucosa from one day before chemoradiotherapy starts through two weeks after the completion of the radiotherapy.

Secondary

MeasureTime frame
subjective dryness/ oral cavity quality/ saliva severity/ inflamation in oral cavity pain/ oral cavity food intake aspiration pneumonia

Countries

Japan

Contacts

Public ContactSatomi Miki

Osaka University Hospital East 13th Floor

mikistm@hosp.med.osaka-u.ac.jp06-6879-6500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026